Your browser doesn't support javascript.
loading
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Schmithals, Christian; Köberle, Verena; Korkusuz, Hüdayi; Pleli, Thomas; Kakoschky, Bianca; Augusto, Eduardo Alonso; Ibrahim, Ahmed Atef; Arencibia, Jose M; Vafaizadeh, Vida; Groner, Bernd; Korf, Horst-Werner; Kronenberger, Bernd; Zeuzem, Stefan; Vogl, Thomas J; Waidmann, Oliver; Piiper, Albrecht.
Afiliação
  • Schmithals C; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Köberle V; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Korkusuz H; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt, Germany.
  • Pleli T; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Kakoschky B; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Augusto EA; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Ibrahim AA; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany. The Immunology and Infectious Diseases Laboratory, Therapeutic Chemistry Department, The National Research Center, Dokki, Cairo, Egypt.
  • Arencibia JM; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Vafaizadeh V; Georg-Speyer Haus, Frankfurt am Main, Germany.
  • Groner B; Georg-Speyer Haus, Frankfurt am Main, Germany.
  • Korf HW; Institute of Anatomy 2, University Hospital Frankfurt, Frankfurt, Germany.
  • Kronenberger B; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Zeuzem S; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Vogl TJ; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
  • Waidmann O; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
  • Piiper A; Department of Medicine 1, University Hospital Frankfurt, Frankfurt, Germany. piiper@med.uni-frankfurt.de.
Cancer Res ; 75(15): 3147-54, 2015 Aug 01.
Article em En | MEDLINE | ID: mdl-26239478
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Compostos de Fenilureia / Doxorrubicina / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Compostos de Fenilureia / Doxorrubicina / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos